Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Wedmont Private Capital

Wedmont Private Capital lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,102 shares of the medical equipment provider’s stock after buying an additional 431 shares during the period. Wedmont Private Capital’s holdings in Intuitive Surgical were worth $3,341,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in ISRG. Godsey & Gibb Inc. grew its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $33,000. Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the 3rd quarter worth approximately $38,000. DT Investment Partners LLC raised its position in Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after buying an additional 36 shares during the last quarter. Finally, Mark Sheptoff Financial Planning LLC acquired a new stake in Intuitive Surgical during the 2nd quarter valued at approximately $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Raymond James raised their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. Wells Fargo & Company raised their target price on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Mizuho boosted their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Royal Bank of Canada raised their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Stock Down 1.8 %

NASDAQ:ISRG traded down $10.10 on Monday, reaching $537.37. The company’s stock had a trading volume of 720,946 shares, compared to its average volume of 1,247,569. Intuitive Surgical, Inc. has a 12-month low of $355.17 and a 12-month high of $556.23. The stock has a 50 day moving average price of $535.93 and a 200 day moving average price of $495.17. The firm has a market cap of $191.40 billion, a price-to-earnings ratio of 86.39, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 48,190 shares of company stock valued at $25,012,927. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.